azathioprine has been researched along with Chronic Liver Failure in 4 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Secondary outcomes include safety and tolerability of MMF and azathioprine, time to remission, changes in Model For End-Stage Liver Disease (MELD)-score, adverse events, and aspects of quality of life." | 3.11 | Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial. ( Bakker, SF; Bartelink, M; Beuers, UHW; Biewenga, M; de Boer, YS; de Jonge, HJM; Drenth, JPH; Gevers, TJG; Gisbertz, IAM; Guichelaar, MMJ; Levens, AD; Pape, S; Pronk, MAMCB; Sebib Korkmaz, K; Sijtsma, MGM; Snijders, RJALM; Soufidi, K; Stoelinga, AEC; van den Berg, AP; van den Brand, FF; van der Meer, AJ; van Gerven, NMF; van Hoek, B; Vanwolleghem, T; Verdonk, RC; Verwer, BJ; Vrolijk, JM, 2022) |
| "An increased risk of colorectal cancer (CRC) is present also after LT in IBD patients with primary sclerosing cholangitis (PSC)." | 2.50 | Clinical management of inflammatory bowel disease in the organ recipient. ( Indriolo, A; Ravelli, P, 2014) |
| "Without prompt immunosuppressive treatment, autoimmune hepatitis is a devastating, albeit rare, liver disease." | 2.47 | Pharmacological management of autoimmune hepatitis. ( Mieli-Vergani, G; Vergani, D, 2011) |
| "16." | 1.46 | Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease? ( Jain, V; Kathuria, R; Krishnani, N; Kumari, N; Poddar, U; Sarma, MS; Srivastava, A; Yachha, SK, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snijders, RJALM | 2 |
| Stoelinga, AEC | 2 |
| Gevers, TJG | 2 |
| Pape, S | 2 |
| Biewenga, M | 2 |
| Verdonk, RC | 2 |
| de Jonge, HJM | 2 |
| Vrolijk, JM | 2 |
| Bakker, SF | 2 |
| Vanwolleghem, T | 2 |
| de Boer, YS | 2 |
| Pronk, MAMCB | 2 |
| Beuers, UHW | 2 |
| van der Meer, AJ | 2 |
| van Gerven, NMF | 2 |
| Sijtsma, MGM | 2 |
| Verwer, BJ | 2 |
| Gisbertz, IAM | 2 |
| Bartelink, M | 2 |
| van den Brand, FF | 2 |
| Sebib Korkmaz, K | 2 |
| van den Berg, AP | 2 |
| Guichelaar, MMJ | 2 |
| Soufidi, K | 2 |
| Levens, AD | 2 |
| van Hoek, B | 2 |
| Drenth, JPH | 2 |
| Jain, V | 1 |
| Srivastava, A | 1 |
| Yachha, SK | 1 |
| Kumari, N | 1 |
| Kathuria, R | 1 |
| Sarma, MS | 1 |
| Poddar, U | 1 |
| Krishnani, N | 1 |
| Indriolo, A | 1 |
| Ravelli, P | 1 |
| Vergani, D | 1 |
| Mieli-Vergani, G | 1 |
2 reviews available for azathioprine and Chronic Liver Failure
| Article | Year |
|---|---|
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Gra | 2014 |
Pharmacological management of autoimmune hepatitis.
Topics: Adult; Azathioprine; Child; Disease Progression; End Stage Liver Disease; Hepatitis, Autoimmune; Hum | 2011 |
1 trial available for azathioprine and Chronic Liver Failure
1 other study available for azathioprine and Chronic Liver Failure
| Article | Year |
|---|---|
Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease?
Topics: Adolescent; Alanine Transaminase; Ascites; Aspartate Aminotransferases; Autoantibodies; Autoimmune D | 2017 |